A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer
Clinical trial NCT02407054 · COMPLETED
Trial details
- NCT number
- NCT02407054
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-29
- Primary completion
- 2018-09-26
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.